BioCatalystWatch
ANABWorkspace / ANAB / OverviewCompany library
Price
Market cap
Next catalystDec 12, 2026imsidolimab · Regulatory decisionCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

ANB033

CD122

Upcoming / outlook

  • Timing and evidence

ANB033

CD122

PreINDP1P2P3FilingApproved
Upcoming / outlook

ANB033

CD122

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ANB033

CD122

Upcoming / outlook

  • Timing and evidence

ANB033

CD122

PreINDP1P2P3FilingApproved
Upcoming / outlook

ANB033

CD122

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

ANB102

BDCA2

PreINDP1P2P3FilingApproved

Partner / License out

imsidolimab

IL-36R

PreINDP1P2P3FilingApproved
Upcoming / outlook

PD-1

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Approved / commercial

PD-1

Approved

PreINDP1P2P3FilingApproved

History / paused

imsidolimab

IL-36R

PreINDP1P2P3FilingApproved
imsidolimab

IL-36R

PreINDP1P2P3FilingApproved
imsidolimab

IL-36R

PreINDP1P2P3FilingApproved
imsidolimab

IL-36R

PreINDP1P2P3FilingApproved
imsidolimab

IL-36R

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ANAB SEC archive